Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naseem A Charoo

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|December 21, 2019
Integrating QbD Tools for Flexible Scale-Up Batch Size Selection for Solid Dosage FormsNaseem A Charoo, Ziyaur Rahman
Journal of Pharmaceutical Sciences|January 18, 2003
Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studiesNaseem A Charoo, Kanchan Kohli, Asgar Ali
Journal of Pharmaceutical Sciences|July 25, 2025
Risk based qualification of non-mutagenic impuritiesNaseem A Charoo, Syed Untoo, Mustafa Eltigani
The Journal of Pharmacy and Pharmacology|April 11, 2018
Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin-clavulanic acid orally administered immediate-release products?Naseem A Charoo, Ziyaur Rahman, Areeg Anwer Ali
The Journal of Pharmacy and Pharmacology|April 2, 2015
Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric populationNaseem A Charoo, Rodrigo Cristofoletti, Jennifer B Dressman
International Journal of Pharmaceutics|December 18, 2022
Data integrity issues in pharmaceutical industry: Common observations, challenges and mitigations strategiesNaseem A Charoo, Mansoor A Khan, Ziyaur Rahman
Drug Development and Industrial Pharmacy|December 30, 2016
Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approachNaseem A Charoo, Rodrigo Cristofoletti, Sun K Kim
Journal of Pharmaceutical Sciences|March 19, 2016
Exploratory Investigation of the Limiting Steps of Oral Absorption of Fluconazole and Ketoconazole in Children Using an In Silico Pediatric Absorption ModelRodrigo Cristofoletti, Naseem A Charoo, Jennifer B Dressman
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 23, 2026
Impact of post approval quantitative changes in excipient composition on nitrosamine formation: De-risking strategyNaseem A Charoo, Syed Ahmad Untoo, Ziyaur Rahman
Drug Development and Industrial Pharmacy|March 22, 2003
Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studiesNaseem A Charoo, Kanchan Kohli, Asgar Ali, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|December 21, 2019
Integrating QbD Tools for Flexible Scale-Up Batch Size Selection for Solid Dosage FormsNaseem A Charoo, Ziyaur Rahman
Journal of Pharmaceutical Sciences|January 18, 2003
Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studiesNaseem A Charoo, Kanchan Kohli, Asgar Ali
Journal of Pharmaceutical Sciences|July 25, 2025
Risk based qualification of non-mutagenic impuritiesNaseem A Charoo, Syed Untoo, Mustafa Eltigani
The Journal of Pharmacy and Pharmacology|April 11, 2018
Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin-clavulanic acid orally administered immediate-release products?Naseem A Charoo, Ziyaur Rahman, Areeg Anwer Ali
The Journal of Pharmacy and Pharmacology|April 2, 2015
Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric populationNaseem A Charoo, Rodrigo Cristofoletti, Jennifer B Dressman
International Journal of Pharmaceutics|December 18, 2022
Data integrity issues in pharmaceutical industry: Common observations, challenges and mitigations strategiesNaseem A Charoo, Mansoor A Khan, Ziyaur Rahman
Drug Development and Industrial Pharmacy|December 30, 2016
Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approachNaseem A Charoo, Rodrigo Cristofoletti, Sun K Kim
Journal of Pharmaceutical Sciences|March 19, 2016
Exploratory Investigation of the Limiting Steps of Oral Absorption of Fluconazole and Ketoconazole in Children Using an In Silico Pediatric Absorption ModelRodrigo Cristofoletti, Naseem A Charoo, Jennifer B Dressman
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 23, 2026
Impact of post approval quantitative changes in excipient composition on nitrosamine formation: De-risking strategyNaseem A Charoo, Syed Ahmad Untoo, Ziyaur Rahman
Drug Development and Industrial Pharmacy|March 22, 2003
Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studiesNaseem A Charoo, Kanchan Kohli, Asgar Ali, et al.
Pageof 3